SNN Smith & Nephew plc Orthopedic, Prosthetic & Surgical Appliances & Supplies Best Orthopedic Devices Stocks 2026 →

Smith & Nephew (SNN) Stock: Buy, Sell, or Hold?

$31.09
+0.05 (+0.16%) ▲
5d: -2.87% 30d: +11.51% 90d: +4.29%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (38%)
Quality Score
40/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$27.86 – $31.09
Position: SLIGHTLY HIGH
Forward P/E & Valuation
13.1x CHEAP
vs 14.7x historical avg
Wall Street Target
$33.19
+6.9% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$29.60 / $33.00
Trend: Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
â„šī¸ NEUTRAL: SNN is fairly priced but lacks strong directional signals. At -3.8% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.

Get Alerted When SNN Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$49.31
Based on 7.2% avg growth
INTRINSIC VALUE TODAY
$30.62
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.7x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: SNN is currently trading at $31.09, which is considered slightly high relative to its 30-day fair value range of $27.86 to $31.09. From a valuation perspective, the stock is trading at a discount (Forward PE: 13.1) compared to its historical average (14.7). Remarkably, the market is currently pricing in an annual earnings decline of 3.8% over the next few years. This pessimistic expectation contrasts with the company's recent 5.7% earnings growth, suggesting potential undervaluation if the company simply maintains stability.

Technical Outlook: Technically, SNN is in a downtrend. Immediate support is located at $29.60, while resistance sits at $33.00.

Market Sentiment: SNN scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Historical Trading Range $27.86 - $31.09
Company Quality Score 40/100 (SELL)
Volume Confirmation HIGH
Confidence Score 38.1%

Trading Range & Key Levels

30-Day Trading Range $27.86 - $31.09
Current vs Trading Range SLIGHTLY HIGH
Support Level $29.60
Resistance Level $33.00
Current Trend Downtrend
Technical data as of Nov 12, 2026

Quantitative Signal Breakdown

  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • NEUTRAL: Near Wall St target ($33.19)
  • WARNING: Composite score 40/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) 13.08
Wall Street Target $33.19 (+6.9%)
Revenue Growth (YoY) 4.6%
Earnings Growth (YoY) 5.7%
Profit Margin 10.1%
Valuation Discount vs History -3.8% cheaper
PE vs Historical 13.1 vs 14.7 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -3.8% (market-implied from PE analysis)
1-Year Target $29.86 (-4%)
2-Year Target $28.73 (-8%)
3-Year Target $27.63 (-11%)
3-Yr Target (if PE normalizes) (PE: 13→15) $31.05 (0%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 19.9, Growth: 10.4%) $63.44 (+104%)
Base: (SPY PE: 13.1, Growth: 10.4%) $41.80 (+35%)
Bear: (PE: 11.1, Growth: 10.4%) $35.53 (+15%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (21x PE), but valuation improves significantly next year (13x PE) as earnings recover.
Trailing PE: 21.03 | Current EPS (TTM): $1.47
Bull Case $54.89 (+77%)
Analyst growth 61.4%, PE expands to 23.1
Base Case $49.90 (+61%)
Market implied 61.4%, PE stable at 21.0
Bear Case $21.03 (-32%)
Severe decline -20.0%, PE contracts to 17.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 13.1 to 14.7
Stabilization Target: $34.87 (+12.3%)
PE Expansion Potential: +12.3%
Share SNN Analysis

Share this live SNN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (SNN)

Bullish 1 Retail Mentions
Reddit / WSB Comments
1
Bullish
Last Tracked
Apr 8, 2026
Daily AI digest
AI Retail Discussion Summary: Reddit & WallStreetBets discussions on SNN are bullish (sentiment score +0.13) across 1 tracked comments.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 2:51 PM ET
Data refreshes hourly during market hours. Next update: 3:51 PM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for SNN.

Create Free Account

Already have an account? Log In

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
DXCM
DexCom Inc
STRONG BUY
29 analysts
$98 54 HOLD
SYK
Stryker Corporation
STRONG BUY
30 analysts
$340 45 HOLD
ABT
Abbott Laboratories
STRONG BUY
28 analysts
$119 48 HOLD
EW
Edwards Lifesciences Corp
STRONG BUY
30 analysts
$112 33 SELL
GEHC
GE HealthCare Technologiâ€Ļ
STRONG BUY
22 analysts
$88 30 SELL

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive SNN Research Pages
SNN Technical Chart SNN Price Prediction SNN Intrinsic Value DCF SNN Earnings Date SNN Investment Advisor SNN Fair Price Analyzer SNN Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals